ESC Premium Access

Novel biomarker algorithmic panel measuring permutations of immune response to cardiac endothelial injury and global risk factors identifies patients at risk of acute coronary syndrome (ACS)

Congress Presentation

About the speaker

Professor Douglas Harrington

GuardaHeart Foundation, Irvine (United States of America)
0 follower

6 more presentations in this session

Serum sLOX-1 concentrations are associated with 2- year major adverse cardiovascular and cerebrovascular events in patients after percutaneous coronary intervention: A multicenter pilot study

Speaker: Doctor Z. Zhao (Fuzhou, CN)


Plasma proteomics in healthy individuals predict myocardial infarction

Speaker: Ms R. Hoogeveen (Amsterdam, NL)


The protein APRIL predicts adverse outcomes in DAPT patients better than NT-proBNP and troponin

Speaker: Professor C. Pemberton (Christchurch, NZ)


GLP-1 levels predict cardiovascular risk in patients with acute myocardial infarction

Speaker: Doctor M. Lehrke (Aachen, DE)


The novel small leucin-rich repeat protein podocan is an independent predictor of major adverse cardiac events in patients with angiographically-defined coronary artery disease

Speaker: Doctor K. watthanasuntorn (Cooperstown, US)


Access the full session

Poster Session 2 - Acute Coronary Syndromes: Biomarkers

Speakers: Professor D. Harrington, Doctor Z. Zhao, Ms R. Hoogeveen, Professor C. Pemberton, Doctor M. Lehrke...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb